Pharmalittle: We’re reading about plans for generic Wegovy, cough syrup warnings, and more
Biocon is developing a generic version of Novo Nordisk’s Wegovy and is prepared to conduct a clinical trial next year if needed.
Biocon is developing a generic version of Novo Nordisk’s Wegovy and is prepared to conduct a clinical trial next year if needed.
This report describes the widening gap in preventable early deaths between rural and urban areas.
Tawana Thomas-Johnson discusses her role as the Senior Vice President and Chief Diversity Officer at the American Cancer Society (ACS). She manages both internal and…
Breast cancer cases are increasing among younger women, which means it now makes sense to start regular screening younger, a federal task force says.
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana…
Novo Nordisk on Thursday defended the prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy amid a Senate probe into what the company…
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big…
This report describes emergency department visits for traffic-related pedestrian injuries.
Over the last decade, private equity firms acquired scores of wheelchair makers. Now, users routinely wait months to get their chairs repaired.